Skip to main content
. 2019 Dec 16;49(6):1789–1799. doi: 10.3906/sag-1903-225

Table 1.

Experimental design.

Group n Agent (i.p.)
CONT 8 1 mL/kg* saline
CP 8 10 mg/kg* cisplatin
NAC-250 8 250 mg/kg* N-acetylcysteine
CP+NAC 8 10 mg/kg* cisplatin + 4 h later and 2 consecutive days 250 mg/kg* N-acetylcysteine

*: Rat body weight; n: number of rats in each group; CONT: control group; CP: cisplatin group; NAC-250: N-acetylcysteine group; CP+NAC: cisplatin plus N-acetylcysteine group; i.p.: intraperitoneal.